The Effect of Subcutaneous Ghrelin On Appetite And Nutritional Status In Patients Receiving Maintenance Peritoneal Dialysis

ISRCTN ISRCTN93119886
DOI https://doi.org/10.1186/ISRCTN93119886
Secondary identifying numbers N0016148177
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
14/02/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Stephen Bloom
Scientific

6th Floor, Commonwealth Bldg.
Imperial College School of Medicine
Hammersmith Hospital
Du Cane Road
London
W12 0HS
United Kingdom

Phone +44 (0)20 8383 3242
Email s.bloom@imperial.ac.uk

Study information

Study designRandomised double blind cross over study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectivesThe short term administration of ghrelin to patients with anorexia with end stage kidney disease will result in increased appetite and calorie intake
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedUrological and Genital Diseases: Kidney disease
InterventionGhrelin vs placebo
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Subcutaneous Ghrelin
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date13/03/2004
Completion date13/03/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants12 volunteers
Key inclusion criteriaPatients with end stage kidney disease
Key exclusion criteriaNot provided at time of registration
Date of first enrolment13/03/2004
Date of final enrolment13/03/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

6th Floor, Commonwealth Bldg.
London
W12 0HS
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Hammersmith Hospital NHS Trust (UK) - NHS R&D Support

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2005 Yes No